CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 314 | 353 | 88.9% | |
| CKD 5 | 2012 | 384 | 446 | 86.1% | |
| CKD 5 | 2013 | 439 | 516 | 85.1% | |
| CKD003 | 2014 | 457 | 536 | 85.3% | |
| CKD003 | 2015 | 513 | 609 | 84.2% | |
| NM84 | 2016 | 396 | 537 | 73.7% | |
| NM84 | 2017 | 441 | 640 | 68.9% | |
| NM84 | 2018 | 421 | 622 | 67.7% | |
| NM84 | 2019 | 402 | 598 | 67.2% | |
| NM84 | 2020 | 438 | 651 | 67.3% | |
| NM84 | 2022 | 477 | 693 | 68.8% |
